The company's net profit dropped 11.7% to Rs 659 crore, weighed down by higher input costs, operating expenses, and finance charges.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On ...

Morgan Stanley acquired a stake in Cigniti Technologies through a block deal worth Rs 26 crore, purchasing shares at a 9.5% ...